Jun 15, 2026 09:31AM
May 5, 2026 10:44AM
Mar 16, 2026 06:00PM
Feb 26, 2026 12:21PM
Oct 21, 2025 04:01PM
Sep 25, 2025 06:50AM
Jul 10, 2025 06:22AM Rhythm Pharmaceuticals prices $175 million stock offering at $85 per share
Jul 10, 2025 06:21AM
Jul 9, 2025 04:16PM
Jul 9, 2025 04:16PM
Jul 9, 2025 12:47PM
Jul 9, 2025 09:15AM
May 29, 2025 08:36AM
Apr 7, 2025 07:27AM Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)
Mar 11, 2025 09:01AM
Mar 5, 2025 06:44AM
Dec 19, 2024 09:42AM
Nov 6, 2024 08:00AM
Oct 25, 2023 08:00AM
Apr 27, 2023 11:57AM
Oct 25, 2022 08:00AM Rhythm Pharmaceuticals to Present Full Data from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity at ObesityWeek® 2022
Oct 25, 2022 08:00AM
Sep 19, 2022 04:01PM
Sep 19, 2022 04:01PM
Sep 15, 2022 09:17AM
Sep 15, 2022 05:49AM
Sep 14, 2022 10:20PM
Sep 14, 2022 10:20PM Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
Sep 14, 2022 05:58PM
Sep 14, 2022 04:01PM
Sep 14, 2022 04:01PM
Sep 14, 2022 04:01PM
Jul 19, 2022 05:32PM
Jul 12, 2022 09:36AM
Jun 17, 2022 06:03AM Rhythm Pharmaceuticals (RYTM) PT Raised to $25 at Stifel After BBS Approval
Mar 2, 2022 06:23AM
Nov 9, 2021 04:01PM
Nov 9, 2021 04:01PM
Mar 15, 2021 08:56AM
Mar 1, 2021 10:51AM
Feb 10, 2021 05:23PM
Feb 10, 2021 05:23PM Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Feb 5, 2021 06:12AM
Feb 4, 2021 09:49PM
Feb 4, 2021 09:49PM
Feb 3, 2021 04:02PM
Feb 3, 2021 04:01PM
Feb 3, 2021 04:01PM
Jan 27, 2021 10:53AM UPDATE: Correction: Rhythm Pharmaceuticals (RYTM) PT Raised to $67 at Stifel, Following Clinical Update
Jan 26, 2021 08:58AM

42,990 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All